NCT04379817View on ClinicalTrials.gov

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 25, 2020

Primary Completion Date

May 23, 2024

Study Completion Date

May 23, 2024

Conditions
Multiple Myeloma
Interventions
DIAGNOSTIC_TEST

Gallium-68 labelled DOTA-conjugated SSTR targeting peptide PET/CT

Assess somatostatin receptor expression

Trial Locations (1)

1000

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER

NCT04379817 - Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients | Biotech Hunter | Biotech Hunter